Erlonat Tablets - 150 Mg Erlotinib Hydrochloride, Pack Of 30 - Effective Treatment For Non-small Cell Lung Cancer And Pancreatic Cancer

Erlonat Tablets - 150 Mg Erlotinib Hydrochloride, Pack Of 30 - Effective Treatment For Non-small Cell Lung Cancer And Pancreatic Cancer

Get Latest Price

Brand Name :

Erlonat

In Stock

Product Specifications

Origin of Medicine	India
Dosage Form	Oral
Salt Composition	Erlotinib 150 mg
Indication	For treatment of advanced or metastatic non-small cell lung cancer and pancreatic cancer
Pacakaging (Quantity Per Box)	30 tablets
Drug Type	Other, Allopathic
Ingredients	Erlotinib Hydrochloride
Physical Form	Tablets
Function	Other, Anti-cancer (tyrosine kinase inhibitor)
Recommended For	Patients with non-small cell lung cancer (NSCLC) and pancreatic cancer
Dosage	As directed by physician
Dosage Guidelines	Take exactly as prescribed by your doctor. Do not chew or crush the tablet.
Suitable For	Adults
Quantity	30 Tablets per box
Storage Instructions	Store below 30AdegC in a dry place, away from sunlight
Packaging Details	PACK OF 30 TABLETS

Product Overview

Key Features

Company Details

Business Type

Exporter, Distributor, Supplier, Trading Company, Wholesaler

Employee Count

Establishment

2011

Working Days

Monday To Saturday

GST NO

07AFIPJ3910R1Z2

Certification

ISO 9001:2015 CERTIFIED

Explore Related Categories

Tamoxifen Tablets

Abiraterone Acetate Tablets

Anastrozole Tablet

Letrozole Tablet

Olaparib Tablet

Cyclophosphamide Tablets

Sorafenib Tablets

Capecitabine Tablet

Ethionamide Tablets

Erlotinib Tablets

Everolimus Tablets

Gefitinib Tablets

More Products From This Seller

Docekast Docetaxel Injection - Physical Form: Liquid

Heptos RIBAVIRIN 200MG CAPSULES - 200 mg, Ribavirin Active Ingredient | Prescription Drug for Medical Guidance Use

ARMOTRAZ - 1 mg Anastrozole Tablets | Anti-Cancer Treatment, Pack of 10 Tablets

Alphalan Melphalan Tablets - 2MG & 5MG Strengths | 25-Tablet Packaging, Prescription Drug for Medical Use

X-TRANT ESTRAMUSTINE PHOSPHATE CAPSULES - Prescription Medication for Effective Treatment | Medical Guidance Required, Do Not Share With Others

BENDIT BENDAMUSTINE INJECTION - Injectable Solution , Prescription Drug for Chemotherapy Treatment Under Medical Guidance

Bortenat - 2 mg & 3.5 mg Injectable Solution | Normal Smell, High-Quality Prescription Formulation

ERLOCIP ERLOTINIB 150MG TABLETS - Erlotinib Hydrochloride, 150 Mg Strength, Pack Of 30 Tablets | Prescription Medicine For Tumor Treatment

ZOLDONAT ZOLEDRONIC INJECTION - 4 Mg/Vial, Intravenous Administration , Lyophilized Single Dose for Osteoporosis, Paget's Disease, Bone Cancer Treatment

VEENAT IMATINIB CAPSULES - Imatinib Mesylate 100mg, Protein-Tyrosine Kinase Inhibitor for Philadelphia Chromosome Positive CML Treatment

Seller Details

Radhakishan Pharmaceuticals

GST - 07AFIPJ3910R1Z2

Delhi, Delhi

Proprietor

Mr. Deepak Jindal

Members since

16 Years

Address

Shop No.1, Second Floor, Property No. 4634/1, Plot No-19, Ward No.11, Ansari Road, Daryaganj, Delhi, Delhi, 110002, India

erlonat tablet in Delhi

Report incorrect details

Recommended Products

Erlonat 150 mg Tablets - 30 Tablets, Blue Color, Effective Treatment for Non-Small Cell Lung and Pancreatic Cancer

Biogen India

ERLONAT Erlotinib Tablets 150 Mg - Erlotinib Hydrochloride, Pack Of 30 Tablets | Prescription Medication, Use Under Medical Guidance

Radhakishan Pharmaceuticals

Erlonat - Erlotinib Hydrochloride 150 Mg Tablets | Non-Small Cell Lung Cancer Treatment, Pack of 30 Tablets

Radhakishan Pharma

Erlonat Tablet - Tablets | Effective Anticancer Medication, High Bioavailability, Targeted Therapy Solution

3s Corporation

ERLONAT 150 MG ERLOTINIB TABLETS - Erlotinib Hydrochloride, 150 Mg Strength, Pack of 30 Tablets | Prescription Drug for Medical Use

Radhakishan Pharmaceuticals

Erlonat Tablets - 100mg Erlotinib | Targeted Therapy for Cancer Treatment, External Use Drug, Suitable for Adults and Teenagers

3s Corporation

Erlonat 150 Mg Tablet

3s Corporation

ERLONAT HYDROCHLORIDE TABLETS - 150 Mg Strength, Pack Of 30 Tablets | Contains Erlotinib Hydrochloride for Targeted Cancer Therapy

Radhakishan Pharmaceuticals

ERLONAT ERLOTINIB 100 MG TABLETS - Contains Erlotinib Hydrochloride, Formulated as 100 Mg Tablets, Pack of 30 Tablets, Effective for Lung and Pancreatic Cancer Treatment

Radhakishan Pharmaceuticals

Compare With Similar Products

Product Name

ERLONAT ERLOTINIB 150 MG TABLETS

Erlotinib Tablet

Erlonat 100mg Tablet (Erlotinib (100mg) - Natco Pharma Ltd

Buyer Feedback

Origin Of Medicine

India

Pacakaging (Quantity Per Box)

30 tablets

30 Tablets

Drug Type

Other, Allopathic

General Medicines

Other Types

Ingredients

Erlotinib Hydrochloride

Erlotinib

Physical Form

Tablets

Function

Other, Anti-cancer (tyrosine kinase inhibitor)

Anti-Cancer

Recommended For

Patients with non-small cell lung cancer (NSCLC) and pancreatic cancer

Non-small cell lung cancer, Pancreatic cancer

Dosage

As directed by physician

As per suggestion

100mg

Dosage Guidelines

Take exactly as prescribed by your doctor. Do not chew or crush the tablet.

As Per Doctor recommended

Suitable For

Adults

Teenagers, Women, Adults, Aged Person

Quantity

30 Tablets per box

30 Tablets in a bottle Container

Storage Instructions

Store below 30AdegC in a dry place, away from sunlight

Dry Place

Store in a Dry Place

Packaging Details

PACK OF 30 TABLETS

1 x 30 Tablets in a bottle

Price Or Price Range

100.00 INR (Approx.)

9800 INR (Approx.)

Minimum Order Quantity

50 Box/Boxes

1 Bottle Bottle/Bottles

Payment Terms

Cash in Advance (CID)

Cash on Delivery (COD), Cash Advance (CA), Delivery Point (DP), Letter of Credit (L/C), Letter of Credit at Sight (Sight L/C), Western Union, Others, Cash Against Delivery (CAD), Telegraphic Transfer (T/T), Days after Acceptance (DA), Cash in Advance (CID), Cheque

Supply Ability

1000000 Per Day

1000 Per Day

Delivery Time

45 Days

24-48 Hours

Main Export Market(s)

Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Western Europe, Australia, Eastern Europe, Middle East, South America, Asia, Central America, North America, Africa

Main Domestic Market

All India, South India, Central India, West India, North India, East India, Gujarat, Karnataka, Kerala, Lakshadweep, Mizoram, Meghalaya, Manipur, Andhra Pradesh, Bihar, Chandigarh, Daman and Diu, Goa, Jharkhand, Odisha, Punjab, Assam, Delhi, Dadra and Nagar Haveli, Andaman and Nicobar Islands, Arunachal Pradesh, Chhattisgarh, Haryana, Himachal Pradesh, Jammu and Kashmir, Madhya Pradesh, Maharashtra, Nagaland, Rajasthan, Sikkim, Tamil Nadu, Telangana, Tripura, Pondicherry, Uttar Pradesh, Uttarakhand, West Bengal

All India

Certifications

WHO-GMP

ISO 9001;2015Drug LicenseExports and Imports LicenseFood license

Sold By

Radhakishan Pharmaceuticals
Delhi, Delhi